Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business
  • interests

Trending on Bing

RV crashes donut house
Charged with assault
3 dead in hit-and-run
Plane crashes in lake
Catches COVID again
Shooting an ‘accident’
Princeton legend
Wins Kenyan presidency
New 'Saw' movie in '23
Returns to directing
Delivers nuke response
Man shoots, kills bear
Guilty plea expected
Files for divorce
Boston's new top cop
UK training Ukrainians
Death threat claim
Bus crashes into home
Family seeks $35M
Blood triggered aging
‘Propaganda’ criticism
New armored dinosaur
Says FBI has passports
Voting data copied
Alligator attack in SC
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
9,270 results
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce Trials
BioNTech and its U.S. partner Pfizer have already begun manufacturing Covid-19 boosters that are adapted for multiple Omicron ...
Forbes on MSN.com
7d
BioNTech, Pfizer could deliver Omicron-adapted COVID-19 vaccines in October
BioNTech and Pfizer announced trials this month for their adapted COVID-19 vaccines, to fight faster-spreading Omicron ...
UPI.com on MSN.com
7d
COVID-19 vaccine maker BioNTech expects updated omicron-specific shots by October
BioNTech, with its partner Pfizer, expects to begin deliveries of two omicron-adapted vaccines as soon as October in time for ...
Washington Examiner on MSN.com
7d
Pfizer, BioNTech to study 'bivalent' booster as FDA weighs approach
The small-scale study is part of the companies’ efforts to update their vaccine in time for a potential fall vaccination ...
BioPharma Dive
19d
U.S. to Offer Updated COVID Booster Shots in September
The Biden administration plans to begin a COVID-19 booster campaign with reformulated vaccines in September. The new boosters ...
WebMD
12d
Moderna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future’
4/5-containing vaccine it’s developing with BioNTech BNTX ... He told investors that Pfizer and the FDA have agreed that the application for the updated booster will include “safety and ...
MarketWatch17d
UPDATE 2-BioNTech expects Omicron-adapted vaccine deliveries as soon as October
BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth quarter, the German biotech firm said on Monday as it reaffirmed its ...
YAHOO!Finance
7d
BioNTech Announces Second Quarter Financial Results and Corporate Update
Second quarter revenues of EUR3.2 billion1, net profit of EUR1.7 billion and fully diluted earnings per share of EUR6.45 ($6.872) as well as first half ...
MarketWatch
7d
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
NEW YORK and MAINZ, Germany, July 27, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind ...
Yahoo Finance19d
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
NEW YORK and MAINZ, Germany, July 27, 2022 — Pfizer Inc. (NYSE ... kinds of immunocompromise a single booster dose to individuals 5 through 11 years of age who have completed a primary series with ...
Yahoo News19d
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
NEW YORK and MAINZ, Germany, July 27, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer ...
Yahoo Sport Australia19d
© 2022 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback